The Brain Health Study: A Pragmatic, Patient-Centered Trial

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

3417 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-29

Study Completion Date

2025-04-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Brain Health Study: A Pragmatic, Patient-Centered Trial

NCT05905796

Dementia Alzheimer Disease

COMPLETED NA

TabCAT Brain Health Assessment in Primary Care

NCT06090578

Mild Cognitive Impairment Dementia

RECRUITING NA

Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research: Prospective Readiness Cohort Study

NCT02114372

Alzheimer's Disease Plaque, Amyloid

COMPLETED

Community-based Brain Health Program to Address Dementia Risk

NCT05529706

Dementia Alzheimer Disease

COMPLETED NA

Remote Sensing for ADRD-Specific Activities Identification in Older Adults

NCT07120347

Alzheimer Disease and Related Dementias (ADRD) Mild Cognitive Impairment (MCI)

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

eRADAR stands for "electronic health record (EHR) Risk of Alzheimer's and Dementia Assessment Rule." It is a low-cost tool or algorithm that uses readily available EHR data elements to identify high-risk patients. We will conduct a pragmatic randomized controlled trial to assess the impact of implementing eRADAR as part of a supported outreach process on dementia detection rates. We will also explore the impact of eRADAR implementation on healthcare utilization and patient experience.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dementia Alzheimer Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Brain Health Intervention

* Calculate eRADAR scores using EHR data to identify eligible individuals
* Invite eligible individuals for brain health assessment visit
* Enter results of brain health assessment visit into EHR
* Provide summary of results and recommended next steps to the Primary Care Physician and participant

Group Type EXPERIMENTAL

Brain Health Assessment

Intervention Type OTHER

Research interventionists, who will be trained and licensed health practitioners (e.g., social workers), will ask participants about changes in memory or thinking and daily function, screen for depression, and administer a standard cognitive screening test. They will use a standardized note template to document results in the participant's EHR. Research interventionists will notify participants and PCPs if follow-up is recommended.

Usual care

Individuals who meet eligibility criteria will receive usual care.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Brain Health Assessment

Research interventionists, who will be trained and licensed health practitioners (e.g., social workers), will ask participants about changes in memory or thinking and daily function, screen for depression, and administer a standard cognitive screening test. They will use a standardized note template to document results in the participant's EHR. Research interventionists will notify participants and PCPs if follow-up is recommended.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* No prior diagnosis of dementia (defined from EHR diagnosis codes) and not receiving medications for dementia
* Active patient at participating clinic
* Adequate data to calculate eRADAR score